These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29960957)

  • 1. Phytobezoar and duodenal ulcer as complication of Duodopa therapy in a patient affected by Parkinson's disease.
    Cerrone P; Marchese M; Pistoia MA; Marini C
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29960957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
    Zulli C; Sica M; De Micco R; Del Prete A; Amato MR; Tessitore A; Ferraro F; Esposito P
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2413-7. PubMed ID: 27338069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study.
    Blaise AS; Baille G; Carrière N; Devos D; Dujardin K; Grolez G; Kreisler A; Kyheng M; Moreau C; Mutez E; Seguy D; Defebvre L
    Rev Neurol (Paris); 2020 May; 176(4):268-276. PubMed ID: 31668287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting the Gordian knot: the blockage of the jejunal tube, a rare complication of Duodopa infusion treatment.
    Negreanu LM; Popescu BO; Babiuc RD; Ene A; Andronescu D; Băjenaru OA
    J Med Life; 2010; 3(2):191-2. PubMed ID: 20968208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Udd M; Lyytinen J; Eerola-Rautio J; Kenttämies A; Lindström O; Kylänpää L; Pekkonen E
    Brain Behav; 2017 Jul; 7(7):e00737. PubMed ID: 28729942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease: A Case Report and Literature Review.
    Ueno T; Hanabata N; Katagai A; Okudera R; Arai A; Tomiyama M
    Intern Med; 2021 Oct; 60(20):3317-3320. PubMed ID: 33867393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients.
    Nyholm D; Odin P; Johansson A; Chatamra K; Locke C; Dutta S; Othman AA
    AAPS J; 2013 Apr; 15(2):316-23. PubMed ID: 23229334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region.
    Dam-Larsen S; Darkahi B; Glad A; Gleditsch D; Gustavsson L; Halttunen J; Johansson KE; Pischel A; Reiertsen O; Törnqvist B; Zebski H
    Scand J Gastroenterol; 2015; 50(12):1500-7. PubMed ID: 26083798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jejunal pulling syndrome: A peculiar LCIG complication.
    Marano M; Pizzicannella M; di Biase L; Rea R; Di Santo A; Martino M; Andrisani G; Pandolfi M; Di Matteo FM; Di Lazzaro V
    Parkinsonism Relat Disord; 2018 Jul; 52():113-114. PubMed ID: 29588146
    [No Abstract]   [Full Text] [Related]  

  • 10. Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion.
    Martino T; Melchionda D; Tonti P; De Francesco V; Lalla A; Specchio LM; Avolio C
    J Neural Transm (Vienna); 2016 Dec; 123(12):1395-1398. PubMed ID: 27614656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Endoscopic Gastrostomy with Jejunal Extension Tube for the Delivery of Levodopa Carbidopa Intestinal Gel: Clinical Practice Guidelines of the Romanian Society of Digestive Endoscopy.
    Gheorghe C; Dumitru E; Ciocîrlan M; Dobru D; Drug V; Goldis A; Jinga M; Manuc M; Saftoiu A; Seicean A; Cotruta B; Bancila I; Pitigoi D; Mercea VA; Tanțău M
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):349-354. PubMed ID: 31517319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of PEG-J associated complications in 14 adult patients treated with levodopa-carbidopa intestinal gel].
    Shimamura M; Shinzaki S; Ikenaka K; Konaka K; Hirozawa D; Ishikura T; Hideshima M; Nakano T; Kitano T; Takehara T; Mochizuki H
    Rinsho Shinkeigaku; 2019 Mar; 59(3):153-156. PubMed ID: 30814443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.
    Poewe W; Bergmann L; Kukreja P; Robieson WZ; Antonini A
    J Parkinsons Dis; 2019; 9(3):531-541. PubMed ID: 31282424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.
    Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M
    Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levodopa-carbidopa intestinal gel treatment introduced by surgical gastrostomy in a patient of Parkinson's disease after Billroth II gastrojejunostomy].
    Nakano T; Hirozawa D; Shimamura M; Sasaki T; Ikenaka K; Mochizuki H
    Rinsho Shinkeigaku; 2018 Sep; 58(9):570-573. PubMed ID: 30175807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results.
    Fernandez HH; Vanagunas A; Odin P; Espay AJ; Hauser RA; Standaert DG; Chatamra K; Benesh J; Pritchett Y; Hass SL; Lenz RA
    Parkinsonism Relat Disord; 2013 Mar; 19(3):339-45. PubMed ID: 23287001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson's disease is safe and may be advantageous.
    Baig F; Boca M; Mooney L; Cheminais L; Selikhova M; Rolinski M; Szewczyk-Krolikowski K; Collin N; Whone A
    Parkinsonism Relat Disord; 2021 Aug; 89():34-37. PubMed ID: 34218045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials.
    Lew MF; Slevin JT; Krüger R; Martínez Castrillo JC; Chatamra K; Dubow JS; Robieson WZ; Benesh JA; Fung VS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):742-8. PubMed ID: 25962554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal burying of the jejunal-tube of a PEG-J levodopa-carbidopa release system for Parkinson's disease. Successful endoscopic management.
    Moralejo Lozano Ó; Barrajón Masa AJ; Colmenares Bulgheroni M
    Rev Esp Enferm Dig; 2021 Mar; 113(3):226-227. PubMed ID: 33207895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.
    Fabbri M; Zibetti M; Beccaria L; Merola A; Romagnolo A; Montanaro E; Ferreira JJ; Palermo S; Lopiano L
    Eur J Neurol; 2019 Mar; 26(3):490-496. PubMed ID: 30347489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.